Mesa Laboratories (NASDAQ:MLAB) Upgraded by Wall Street Zen to Strong-Buy Rating

Mesa Laboratories (NASDAQ:MLAB) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

A number of other analysts also recently commented on MLAB. Wells Fargo & Company upped their target price on Mesa Laboratories from $83.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Mesa Laboratories in a research note on Thursday, January 22nd. Finally, Zacks Research upgraded shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Mesa Laboratories currently has a consensus rating of “Reduce” and an average target price of $94.00.

Mesa Laboratories Trading Up 2.3%

Shares of NASDAQ:MLAB opened at $93.27 on Friday. The company has a quick ratio of 1.44, a current ratio of 1.94 and a debt-to-equity ratio of 0.86. Mesa Laboratories has a 52-week low of $55.45 and a 52-week high of $155.12. The stock has a market cap of $514.85 million, a price-to-earnings ratio of 145.74 and a beta of 0.89. The business has a 50-day moving average price of $82.11 and a 200-day moving average price of $74.90.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Tuesday, February 3rd. The medical instruments supplier reported $3.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.41 by $0.66. Mesa Laboratories had a net margin of 1.51% and a return on equity of 22.02%. The company had revenue of $65.13 million during the quarter, compared to analyst estimates of $63.23 million. Equities analysts predict that Mesa Laboratories will post 8 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Simcoe Capital Management LLC purchased a new stake in Mesa Laboratories during the 3rd quarter valued at about $12,794,000. Boston Partners grew its position in shares of Mesa Laboratories by 2,009.5% in the third quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock valued at $7,664,000 after purchasing an additional 108,936 shares in the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Mesa Laboratories by 218.0% in the third quarter. Diamond Hill Capital Management Inc. now owns 123,381 shares of the medical instruments supplier’s stock valued at $8,268,000 after purchasing an additional 84,582 shares during the last quarter. Roubaix Capital LLC purchased a new position in Mesa Laboratories during the third quarter worth approximately $5,137,000. Finally, Millennium Management LLC increased its stake in shares of Mesa Laboratories by 131.9% in the 3rd quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock worth $8,967,000 after acquiring an additional 76,107 shares during the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.